Skip to content

TOKA: Custom Made Devices for High Tibial Osteotomy (HTO) - Clinical Investigation

Clinical Evaluations of the TOKA Customized Device for High Tibial Osteotomy in the Treatment of Knee Osteoarthritis: a Pilot Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04574570
Acronym
TOKA
Enrollment
25
Registered
2020-10-05
Start date
2020-09-14
Completion date
2023-12-31
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unicompartmental Medial Knee Osteoarthritis

Brief summary

This preliminary pilot study is a single-centre, prospective, uncontrolled, 32-month study to assess the performance of personalised opening wedge High Tibial Osteotomy (HTO) treatment using the TOKA® device and procedure. The medical device being examined is a custom-made device and therefore does not require a CE mark. Furthermore, the study will serve as a useful method of gathering clinical data and measuring device performance, as well as establishing a potential commercial relationship with the hospital administration. Study Objectives:: 1. to assess the morphology of the knee joint and the improvement of OA following the TOKA® treatment. 2. to Assess the functional outcome of the knee joint and the improvement of OA following the TOKA® treatment. Outcomes Evaluations:: 1. The morphology of the knee joint is assessed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the correction angle, hip-knee-ankle angle (HKA - mechanical axis), Mikulicz point (recorded as a percentage of the tibial width from the medial to the lateral region) and posterior slope, using the imaging techniques. 2. The functional outcome of the knee joint is assessed by a) performing a gait analysis of the patients pre-operatively and post-operatively, b) the use of clinical scoring... .

Interventions

Personalised High Tibial Osteotomy (HTO) using a patient-specific fixation plate (TOKA®)

Sponsors

University of Bath
CollaboratorOTHER
3D Metal Printing Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing opening wedge Hight Tibial Osteotomy (HTO) * Patients must have completed a consent form for the study * Patients must be prepared to comply with the pre and post-operative investigations, rehabilitation, attendance schedule and questionnaire schedule of the study * Patient in whom any varus deformity present is \<20° * The diagnosis is of unicompartmental medial osteoarthritis of the knee * Patient has primary diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD) * BMI\<40 * Age range 40 to 65 years

Exclusion criteria

* Refusal to consent to the study * Pregnancy * Prisoners * A patient known to have substance abuse or psychological disorders that could interfere with their ability to comply with the post-operative rehabilitation and assessment schedules * Patients unable to read or understand the patient information leaflet and consent form * Patient has a known sensitivity to device materials. * Patient has a Body Mass Index (BMI) ≥ 40. * Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation. * Patient has received any orthopaedic surgical intervention to the lower extremities within the past year or is expected to require any orthopaedic surgical intervention to the lower extremities, other than the HTO to be enrolled in this study, within the next year. * Patient requires bilateral HTO or has a history of unsuccessful contralateral partial replacement or HTO. * Patient has chronic heart failure (NYHA Stage ≥ 2) * Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. * Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration. * Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days).

Design outcomes

Primary

MeasureTime frameDescription
Morphology Assessment Via Correction Angle AssessmentAt 6 months after surgeryThe device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the correction angle, using image-based techniques.
Morphology Assessment Via Hip-knee-ankle Angle AssessmentAt 6 months after surgeryThe device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the hip-knee-ankle angle (HKA - mechanical axis) reported in degree, using image-based techniques.
Morphology Assessment Via Mikulicz Point AssessmentAt 6 months after surgeryThe device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the Mikulicz point reported in % of the tibial width from the medial to the lateral region, using image-based techniques.
Morphology Assessment Via Posterior Slope AssessmentAt 6 months after surgeryThe device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the posterior slope reported in degree, using image-based techniques.

Secondary

MeasureTime frameDescription
Functional Assessment Via Clinical Scoring - Tegner Score6 month after surgery.The functional assessment is performed via clinical scoring using the Tegner score. Tegner scale value range: \[min / max\]= 0 - 10, higher values mean better outcome.
Functional Assessment Via Clinical Scoring - Knee Society System Score6 months after surgery.The functional assessment is performed via clinical scoring using the knee society system score (KSS). KSS value range: \[min / max\]= 0 - 100, higher values mean better outcome.
Functional Assessment Via Gait Analysis - KinematicsBefore surgeryThe functional assessment is performed via three dimensional gait analysis of the patients before surgery. Relevant kinematic results are reported in terms of joint rotations (in degrees)..
The Functional Assessment Via X-ray ExaminationsBefore surgery and at 1, 3, 6, 12 and 24 months after surgery.The functional assessment is performed via x-ray examinations by reporting knee joint alligments in degrees..
Functional Assessment Via Clinical Scoring - Visual Analogue Scale6 months after surgery.The functional assessment is performed via clinical scoring using the Visual Analogue Scale (VAS). VAS is based on a 10-cm long straight line with one end meaning no pain and the other end meaning the worst pain. The score is from 0 to 10 (0= no pain, 10= worst pain ever)
Functional Assessment Via Gait Analysis - KineticsBefore surgeryThe functional assessment is performed via three dimensional gait analysis of the patients before surgery. Relevant kinetic results are reported in terms of joint moments (in N\*mm, normalized to patient's body weight times height).
Functional Assessment Via Clinical Scoring - Knee Osteoarthritis Outcome Score6 months after surgery.The functional assessment is performed via clinical scoring using the Knee Osteoarthritis Outcome Score (KOOS). KOOS value range: \[min / max\]= 0 - 100, higher values mean better outcome.
Functional Assessment Via Clinical Scoring - European Quality of Life Via 5-Dimensions Questionnaire6 months after surgery.The functional assessment is performed via clinical scoring using the European Quality of life via 5-Dimensions questionnaire (EQ-5D). In this applied scoring system, respondents rank their health status into 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension can be rated from 1 to 3 as follows: 1=no problem, 2=moderate problems or 3=severe problems. The final total score is the sum of the scores given to each dimension and ranges from 5 (best outcome) to 15 (worst outcome).

Countries

Italy

Participant flow

Participants by arm

ArmCount
Interventional Patient
Personalised High Tibial Osteotomy (HTO) using a patient-specific fixation plate (TOKA®)
25
Total25

Baseline characteristics

CharacteristicInterventional Patient
Age, Continuous54.4 years
STANDARD_DEVIATION 7.4
Body Mass Index26.8 kg/m2
STANDARD_DEVIATION 4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
25 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
0 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Morphology Assessment Via Correction Angle Assessment

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the correction angle, using image-based techniques.

Time frame: At 6 months after surgery

Population: Operated Patients

ArmMeasureValue (MEAN)Dispersion
Interventional PatientMorphology Assessment Via Correction Angle Assessment1.5 DegreeStandard Deviation 2
Primary

Morphology Assessment Via Hip-knee-ankle Angle Assessment

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the hip-knee-ankle angle (HKA - mechanical axis) reported in degree, using image-based techniques.

Time frame: At 6 months after surgery

Population: Operated patients

ArmMeasureValue (MEAN)Dispersion
Interventional PatientMorphology Assessment Via Hip-knee-ankle Angle Assessment1.5 DegreeStandard Deviation 2
Primary

Morphology Assessment Via Mikulicz Point Assessment

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the Mikulicz point reported in % of the tibial width from the medial to the lateral region, using image-based techniques.

Time frame: At 6 months after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientMorphology Assessment Via Mikulicz Point Assessment-9.7 % of medial-lateral tibial plateau widthStandard Deviation 8.4
Primary

Morphology Assessment Via Posterior Slope Assessment

The device morphology assessment is performed by verifying the matching between the planned correction and the post-operative imaging results, along with the investigation of the maintenance of the desired correction at the follow-up meetings. These results are measured through the posterior slope reported in degree, using image-based techniques.

Time frame: At 6 months after surgery

Population: Operated patiemts

ArmMeasureValue (MEAN)Dispersion
Interventional PatientMorphology Assessment Via Posterior Slope Assessment0.1 DegreeStandard Deviation 0.3
Secondary

Functional Assessment Via Clinical Scoring - European Quality of Life Via 5-Dimensions Questionnaire

The functional assessment is performed via clinical scoring using the European Quality of life via 5-Dimensions questionnaire (EQ-5D). In this applied scoring system, respondents rank their health status into 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension can be rated from 1 to 3 as follows: 1=no problem, 2=moderate problems or 3=severe problems. The final total score is the sum of the scores given to each dimension and ranges from 5 (best outcome) to 15 (worst outcome).

Time frame: 6 months after surgery.

Population: Operated patients - European Quality of life via 5-Dimensions questionnaire (total) at 6 month after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Clinical Scoring - European Quality of Life Via 5-Dimensions Questionnaire7.5 units on scaleStandard Deviation 0.9
Secondary

Functional Assessment Via Clinical Scoring - Knee Osteoarthritis Outcome Score

The functional assessment is performed via clinical scoring using the Knee Osteoarthritis Outcome Score (KOOS). KOOS value range: \[min / max\]= 0 - 100, higher values mean better outcome.

Time frame: 6 months after surgery.

Population: Operated patients - KOOS (total) at 6 month after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Clinical Scoring - Knee Osteoarthritis Outcome Score81.2 score on a scaleStandard Deviation 9.7
Secondary

Functional Assessment Via Clinical Scoring - Knee Society System Score

The functional assessment is performed via clinical scoring using the knee society system score (KSS). KSS value range: \[min / max\]= 0 - 100, higher values mean better outcome.

Time frame: 6 months after surgery.

Population: Operated patients - KSS (total) at 6 months after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Clinical Scoring - Knee Society System Score93.5 score on a scaleStandard Deviation 13.7
Secondary

Functional Assessment Via Clinical Scoring - Tegner Score

The functional assessment is performed via clinical scoring using the Tegner score. Tegner scale value range: \[min / max\]= 0 - 10, higher values mean better outcome.

Time frame: 6 month after surgery.

Population: Pot operative patients at 6 month after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Clinical Scoring - Tegner Score4.2 score on a scaleStandard Deviation 1.3
Secondary

Functional Assessment Via Clinical Scoring - Visual Analogue Scale

The functional assessment is performed via clinical scoring using the Visual Analogue Scale (VAS). VAS is based on a 10-cm long straight line with one end meaning no pain and the other end meaning the worst pain. The score is from 0 to 10 (0= no pain, 10= worst pain ever)

Time frame: 6 months after surgery.

Population: Operated patients - VAS at 6 month after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Clinical Scoring - Visual Analogue Scale1.3 score on a scaleStandard Deviation 1
Secondary

Functional Assessment Via Gait Analysis - Kinematics

The functional assessment is performed via three dimensional gait analysis of the patients before and after surgery. Relevant kinematic results are reported in terms of joint rotations (in degrees)..

Time frame: 6 months after surgery

Population: Operated Patients - Max Knee Flexion Rotation at 6 months after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Gait Analysis - Kinematics58 DegreeStandard Deviation 6
Secondary

Functional Assessment Via Gait Analysis - Kinematics

The functional assessment is performed via three dimensional gait analysis of the patients before surgery. Relevant kinematic results are reported in terms of joint rotations (in degrees)..

Time frame: Before surgery

Population: Operated Patients - Max Knee Flexion Rotation

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Gait Analysis - Kinematics70.5 DegreeStandard Deviation 5
Secondary

Functional Assessment Via Gait Analysis - Kinetics

The functional assessment is performed via three dimensional gait analysis of the patients before and after surgery. Relevant kinematic results are reported in terms of joint moments (in N\*mm, normalized to patient's body weight times height).

Time frame: at 6 months after surgery

Population: Operated Patients - Max Abduction Moment

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Gait Analysis - Kinetics2.8 % of Body Weight * heightStandard Deviation 0.8
Secondary

Functional Assessment Via Gait Analysis - Kinetics

The functional assessment is performed via three dimensional gait analysis of the patients before surgery. Relevant kinetic results are reported in terms of joint moments (in N\*mm, normalized to patient's body weight times height).

Time frame: Before surgery

Population: Operated Patients - Max Abduction Moment

ArmMeasureValue (MEAN)Dispersion
Interventional PatientFunctional Assessment Via Gait Analysis - Kinetics3.8 % of Body Weight * heightStandard Deviation 1.2
Secondary

The Functional Assessment Via X-ray Examinations

The functional assessment is performed via x-ray examinations by reporting knee joint alligments in degrees..

Time frame: Before surgery and at 1, 3, 6, 12 and 24 months after surgery.

Population: Operated patients at 6 months after surgery

ArmMeasureValue (MEAN)Dispersion
Interventional PatientThe Functional Assessment Via X-ray Examinations181.9 DegreeStandard Deviation 2.6

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026